Corline Biomedical

Corline Biomedical Tangible Book Value per Share

The Tangible Book Value per Share of Corline Biomedical (CLBIO.ST) as of Oct 16, 2026 is 3.66 SEK. In the previous year, Tangible Book Value per Share was 0.52 SEK — a change of 598.86% (higher).

Tangible Book Value per Share

3.66SEK

YoY

598.86%

Last updated:

Tangible Book Value per Share of Corline Biomedical is 2025 3.66 SEK. Tangible Book Value per Share of Corline Biomedical was 2024 0.52 SEK. It decreases by 598.86% higher compared to the previous year.

The Corline Biomedical Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
0.82 SEK
Jan 1, 2019
0.80 SEK
Jan 1, 2020
0.19 SEK
Jan 1, 2021
1.39 SEK
Jan 1, 2022
1.14 SEK
Jan 1, 2023
0.68 SEK
Jan 1, 2024
0.52 SEK
Jan 1, 2025
3.66 SEK
The Corline Biomedical Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
3.66SEK+598.86%
0.52SEK-22.55%
0.68SEK-40.44%
1.14SEK-18.24%
1.39SEK+633.35%
0.19SEK-76.45%
0.80SEK-2.31%
0.82SEK+62.93%
0.51SEK+20.03%
0.42SEK+491.86%
0.07SEK-120.02%
-0.36SEK-40.78%
-0.60SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Corline Biomedical Stock analysis

What does Corline Biomedical do? Corline Biomedical AB, headquartered in Uppsala, Sweden, operates in the Health Care sector, specifically within Pharmaceuticals. The company focuses on the research, development, and commercialization of heparin-based solutions for kidney transplantation, cell therapies, and regenerative medicine applications. Listed on 3 June 2015, Corline Biomedical employs eight people and is dedicated to advancing medical treatments through innovative heparin-based technologies. Corline Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corline Biomedical stock

Tangible Book Value per Share of Corline Biomedical is 3.66 SEK in 2025.

Tangible Book Value per Share of Corline Biomedical changed from 0.52 SEK to 3.66 SEK, representing a 598.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Corline Biomedical since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Corline Biomedical

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Corline Biomedical